ERBB2 and endocervical adenocarcinoma: Among the major histotypes of endocervical adenocarcinomas, HER2 amplification was relatively common in GAC (14.7%, 5/34) and mucinous adenocarcinoma, NOS (10%, 2/20) (Table 1).